Skip to main content

Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease

Medical Oncology volume 17, pages 174–178 (2000)Cite this article

Abstract

The aim of this retrospective study was to evaluate the role of routinely performed bone scintigraphy in the clinical assessment of patients with previously untreated Hodgkin's disease (HD).

One-hundred and eighty-three patients with a median age of 31 yrs (range 16–85) with newly diagnosed HD underwent bone scintigraphy between 1972 and 1995. Bone scintigraphies and skeletal X-ray examinations of patients with any pathological scintigraphic finding were reassessed.

Initially HD bone involvement could be excluded in 173 (95%) of the patients. Among the remaining ten patients, two had diffuse increased tracer uptake but X-rays were normal. One of these patients was classified as normal with regard to HD bone involvement. A bone marrow scintigraphy examination and regression of changes following therapy supported primary osseous involvement in the other patient. Five patients had focal scintigraphic abnormalities but skeletal X-rays remained negative; three of these five patients reported pain in the scintigraphically affected areas, and therefore the suspicion of bone involvement was strong. The remaining three patients had focal findings both on bone scintigraphy and skeletal X-ray examination and were considered as having osseous HD involvement. All seven patients judged to have HD bone involvement were planned to receive combination chemotherapy up-front, irrespective of the scintigraphic findings.

In this series of 183 patients bone involvement was detected in seven patients based on bone scintigraphy/symptoms (n=3), bone marrow scintigraphy/symptoms (n=1), and bone scintigraphy/X-ray examination (n=3). The decision to give multiagent chemotherapy to all patients was not influenced by scintigraphic findings. Therefore, routine bone scintigraphy seems to be of limited value in the clinical assessment of untreated patients with HD.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Kaplan HS.Hodgkin's Disease. Harvard University Press: Cambridge, 2nd edn, 1980, p 220.

    Google Scholar 

  2. Horan FT. Bone involvement in Hodgkin's disease.Br J Surg 1969;56: 277–281.

    PubMed  Article  CAS  Google Scholar 

  3. Stuhlbard J, Ellis FW. Hodgkin's disease of bone: favourable prognostic significance?.Am J Roentgenogr 1965;93: 568–572.

    Google Scholar 

  4. Fucilla IS, Hamann A. Hodgkin's disease in bone.Radiol 1961;77: 53–59.

    CAS  Google Scholar 

  5. Granger W, Whitaker P. Hodgkin's disease in bone with special reference to periosteal reaction.Br J Radiol 1967;40: 939–948.

    PubMed  CAS  Article  Google Scholar 

  6. Fischer AMH, Kendall B, Van Leuven BD. Hodgkin's disease: a radiologic survey.Clin Radiol 1962;13: 115–127.

    Article  Google Scholar 

  7. Perttala Y, Kijanen I. Roentgenologic bone lesions in lymphogranulomatosis maligna: analysis of 453 cases.Ann Clin Gyn Fenn 1965;54: 414–424.

    CAS  Google Scholar 

  8. Shanks SC, Kerley P.A Text-book of X-ray Diagnosis. HK Lewis & Co Ltd: London, 3rd edn, 1959, p 620.

    Google Scholar 

  9. Musshoff K, Busch M, Kaminski H. Hodgkin's disease with bone involvement.Fortschr Roentg Nuklearmed 1964;101: 117–137.

    CAS  Article  Google Scholar 

  10. Newall J. The management of Hodgkin's disease.Clin Radiol 1965;16: 40–50.

    PubMed  Article  CAS  Google Scholar 

  11. Anderson KC, Kaplan WD, Leonard RC, Skarin AT, Canellos GP. Role of 99mTc Methylene diphosphonate bone imaging in the management of lymphoma.Cancer Treat Rep 1985;69: 1347–1351.

    PubMed  CAS  Google Scholar 

  12. Schechter JP, Jones SE, Woolfenden JM, Lilien DL, O'Mara RE. Bone scanning and lymphoma.Cancer 1976;38: 1142–1148.

    PubMed  Article  CAS  Google Scholar 

  13. Ferrant Aet al. Detection of skeletal involvement in Hodgkin's disease: A comparison of radiography, bone scanning, and bone marrow biopsy in 38 patients.Cancer 1975;35: 1346–1353.

    PubMed  Article  CAS  Google Scholar 

  14. Newcomer LNet al. Bone involvement in Hodgkin's disease.Cancer 1982;49: 338–342.

    PubMed  Article  CAS  Google Scholar 

  15. Jacobsson H, Göransson H. Radiological detection of bone and bone marrow metastases.Med Oncol Tumor Pharmacother 1991;8: 253–260.

    PubMed  CAS  Google Scholar 

  16. Silberstein EB.Bone Scintigraphy. Futura: New York, 1984, pp 237–258.

    Google Scholar 

  17. Evens RG. Diagnostic imaging in cancer care. The role of cost/benefit analysis.Cancer 1991;67: 1245–1252.

    PubMed  Article  CAS  Google Scholar 

  18. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease.Cancer Res 1966;26: 1063–1081.

    PubMed  CAS  Google Scholar 

  19. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification.Cancer Res 1971,31: 1860–1861.

    PubMed  CAS  Google Scholar 

  20. Björkholm Met al. Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.Scand J Haematol 1977;19: 487–495.

    PubMed  Article  Google Scholar 

  21. Tullgren Oet al. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. A long-term followup.Cancer 1991;68: 768–775.

    PubMed  Article  CAS  Google Scholar 

  22. Björkholm Met al. Fixed versus response adapted MOPP/ABVD chemotherapy in Hodgkin's disease.Ann Oncol 1995;6: 895–899.

    PubMed  Google Scholar 

  23. Ostrowski MLet al. Osseous Hodgkin disease.Cancer 1999;85: 1166–1178.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Medicine, Division of Hematology, Karolinska Institute and Hospital, S-171 76, Stockholm, Sweden

    O Landgren, U Axdorph, G Grimfors & M Björkholm

  2. Department of Radiology and Nuclear Medicine, Karolinska Institute and Hospital, Stockholm, Sweden

    H Jacobsson

  3. Department of Oncology (Radiumhemmet) for the Stockholm Hodgkin Study Group, Karolinska Institute and Hospital, Stockholm, Sweden

    B Johansson

Authors
  1. O Landgren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U Axdorph
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Jacobsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B Johansson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Grimfors
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Björkholm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Björkholm.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Landgren, O., Axdorph, U., Jacobsson, H. et al. Routine bone scintigraphy is of limited value in the clinical assessment of untreated patients with Hodgkin's disease. Med Oncol 17, 174–178 (2000). https://doi.org/10.1007/BF02780524

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02780524

Keywords

  • Hodgkin's disease
  • bone scintigraphy
  • osseous involvement